In Recognition of Outstanding International Commercial Achievement, Leading Providers of Intelligent Visual Solutions Receive the UK’s Highest Accolade for Business Success
Category : Stocks
HOUSTON, TX–(Marketwired – May 10, 2013) – Era Group Inc. (“Era”), a leading helicopter transport operator based in the United States, today announced it will release financial results for its fiscal year 2013 first quarter after the market closes on Tuesday, May 14, 2013. In connection with the release, Era has scheduled a conference call for Wednesday, May 15, 2013 to begin at 10:00 a.m. ET (9:00 a.m. CT).
Continued here: Era Group Inc. Announces Q1 2013 Earnings Release Call
Leading UK tax expert John Dixon warns companies that they can no longer ignore public unease about tax avoidance.
Visit link: Tax chief wants more transparency
Dr. Wayne Hickory Continues to Be a Leading Invisalign(R) Educator and Practitioner
When does buying the bond of a company make more sense than buying the stock? Money magazine examines industry-leading businesses to find out.
Read more here: Stock or bond? How to play 6 blue-chips
Britain’s leading sandwich chain Pret A Manger has announced a 17% rise in earnings for 2012.
Cultural Festivals, a Leading Art Fair Producer, Opts for FTS Vendor Booth Sales Service
US Poised to Become Leading Market for Mobile Music Streaming as Apple Launches iRadio
Commodity companies lead risers but chip designer hit by downbeat comments ahead of quarterly results
Despite a recovery in the mining sector, leading shares are heading lower again.
With gold stablising after its recent declines – which were based on worries about countries such as Cyprus selling some of their reserves along with signs of slowdown in China – and base metals such as copper recovering, mining shares regained some lost ground.
Fresnillo is up 45p at £11.25, Eurasian Natural Resources Corporation has climbed 9.1p to 247.2p and Xstrata has added 37.2p to 1003.5p.
All ten of the top ten risers in the leading index are commodity companies, as are the top ten in the FTSE 250.
But investors are still cautious, not least following Wall Street’s fall overnight in the wake of the Boston marathon explosions. So the FTSE 100 is down 41.20 points at 6302.40, with little impact from UK inflation figures in line with forecasts.
Ahead of results next week, Arm is among the biggest fallers in the leading index. The chip designer is down 27p at 869.5p as Liberum Capital issued a sell note. Analyst Janardan Menon said:
We expect Arm’s US dollar revenues to be broadly in line with guidance ($250m) and consensus estimates, while sterling revenues are expected to benefit from weakness in the currency. Arm had sequentially guided down its first quarter 2013 revenues, following strength in the fourth quarter of 2012. Going forward we expect year on year revenue growth rates to gradually decelerate as smartphone growth moderates. We also remain concerned about potential gains in smartphone and tablet share by Intel and maintain our sell recommendation on the stock.
In more detail, Menon added:
Our sell recommendation on Arm is based on three factors. 1) an expectation of Intel gaining share in Arm’s key royalty markets – smartphones and tablets. 2) slowing growth rates in the smartphone and tablet markets which are expected to depress Arm’s royalty growth 3) The high multiples the stock is trading at relative to its longer term growth outlook. While we do not expect these concerns to be specifically flagged in the first quarter results, we do expect newsflow in coming quarters to do so.
Elsewhere Associated British Foods has fallen 40p to £18.24 after Credit Suisse cut its recommendation from outperform to neutral.
Burberry is down 33p at £12.51 following disappointing results from luxury goods giant LVMH.
OKLAHOMA CITY, OK–(Marketwired – Apr 16, 2013) – Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, announces the planned expansion of its microbial manufacturing capabilities. In addition to its current 100L Fermenter, Cytovance recently acquired a second 100L and a 1000L Fermenter.